Antidepressants
K. Kavindya M. Fernando
JMJ 1
Contents
• SSRI
• TCA
• SNRI
• Mirtazapine
• Reboxetine
• Reversible MAO inhibitors
JMJ 2
Specific Serotonin
Reuptake Inhibitors
Citalopram, escitalopram, fluoxetine, fluvoxamine,
paroxetine, sertraline
JMJ 3
Action
• Specifically blocks serotonin reuptake pump
JMJ 4
Indications
• Depressive illness
• Generalized anxiety disorder
• Panic disorder
• Obsessive compulsive disorder
• Social phobia
• Post traumatic stress disorder
JMJ 5
Notes on administration
• Administrated as a single daily dose
• Given in the morning
• Start with minimal effective dose
• Action takes 2-3 weeks
• If response is inadequate after 2-3 weeks,
increase dose
• If symptoms persist after tx with maximum
dose for 6 weeks
• Consider another antidepressants
• Lower doses in panic disorder
JMJ 6
Side effects
• Gastrointestinal effects
• Nause, vomiting
• Dyspepsia
• Constipation, diarrhoeas
• Weight loss, weight gain
• Increase risk of GI bleeding
JMJ 7
Side effects
• Serious adverse effects
• Seizures,
• Hyponatremia (syndrome of inappropriate ADH
secretion)
• Increase suicidal risk in children and adolescents
• Hypomania
• Mania
JMJ 8
Side effects
• Others
• Insomnia
• Sedation
• Drowsiness
• Agitation
• Anxiety
• Drymouth, urinary retension
• Erectile dysfunction
• Delayed ejaculation
• Hypersensitivity & rash
JMJ 9
Management of side effects
• Hypernatremia
• Antidepressant induced hyponatremia (SIADH)
• Elderly people are at higher risk
• If features present check serum electrolytes
immediately (dizziness, lethargy, seizures)
• Hyponatremia occurs- stop antidepressants
JMJ 10
Management of side effects
• Hypernatremia
• Serum Na >125mmol/l
• Stop antidepressant
• Monitor Na levels daily
• Fluid restriction
• Seum Na <125 mmol/l
• Stop antidepressant
• Admit to hospital
• Initiate management
JMJ 11
Caution
• Bipolar disorder
• Epilepsy
• Cardiac disease
• Hepatic impairment
• Renal impairment
• Pregnancy
• Brest feeding
JMJ 12
Drug interaction
• Can displace highly protein bound wafarine
and thereby
• increase risk of bleeding,
• Increase risk of GI bleeding with NSAIDs
• Serotonine syndrome with concurrent
MAOI, tricyclics or when several SSRIs
used together
JMJ 13
Tricyclic
Antidepressents
Amitriptiline, clomipramine, doxepin, imipramine,
lofepramine, nortriptyline
Tricyclic related antidepressant – trazadone
JMJ 14
Action
• Blocks reuptake of noradrenalin & serotonin
• Side effects caused by
• Blockage of alpha 1 adrenergic receptors
• H1 histamine receptors
• Muscarinic cholinergic receptors
JMJ 15
Indications
• Depressive illness
• OCD (clomipramine)
• Panic disorder
• Nocturnal enuresis in children
• Neuropathic pain
• Prophylaxis of migraine
JMJ 16
Notes on administration
• Amitriptaline, imipramine, clomipramine
• Dose range 75 -225mg
• Single daily dose
• Dose should be titrated to minimize side
effects
• Start with 25mg
• Increase gradually over a few days to 75mg
• Minimum effective dose 75-150mg
JMJ 17
Notes on administration
• Action takes 2-3 weeks
• If response is inadequate after 2-3 weeks
• Increase the dose
• If symptoms persist after tx with maximum
effective dose for 6 weeks
• Consider change to another rantidepressent
JMJ 18
Side effects
• Anticholinergic effects
• Dry mouth
• Blurred vision
• Urinary retention
• Constipation
• Antiadrenergic effects
• Postural hypotension
• Ejaculatory delay
JMJ 19
Side effects
• Cardiovascular side effects
• Potural hypotension
• Tachycardia
• Arrhythmias
• Sudden death
• Others
• Drowsiness, dizziness, seizure,
• Tremors, weight gain, hyponatremia
• Hypomania, mania
JMJ 20
Serotonin
Noradrenaline
Reuptake Inhibitors
Venelaflaxine
Duloxetine
Desvenlafaxine (not found in SL)
JMJ 21
Action
• Blocks serotonin reuptake pump &
norepinephrine reuptake pump
• Unlike tricyclics, they do not block
• alpha 1 adrenergic receptors,
• H1 histamine receptors
• Muscuranic cholinergic receptors
JMJ 22
Indications
• Depressive illness
• Generalized anxiety disorder
• Panic disorder
• OCD
• Duloxetine – used in diabetic neuropathy
JMJ 23
Notes on administration
• Venalaflexin
• 75-225mg (extended release)
• 75-375mg (normal relase)
• Given as bd dose
• Dosage over 300mg should be given under
observation
JMJ 24
Side effects
• Gastrointestinal effects
• Nause, vomiting
• Dyspepsia
• Constipation, diarrhoeas
• Cardiovascular
• Hypertension
• QT prolongation
• Reports death sue to cardiotoxicity in overdose
JMJ 25
Side effects
• Serious adverse effects
• Hyponatremia (syndrome of inappropriate ADH
secretion)
• Increase suicidal risk in children and adolescents
• Hypomania
• Mania
• Weight loss, weight gain
JMJ 26
Side effects
• Others
• Drowsiness
• Agitation
• Anxiety
• Drymouth, urinary retension
• Sexual dysfunction
• Seizure
• Hypersensitivity & rash
JMJ 27
Caution
• Bipolar disorder
• Epilepsy
• Hypertension
• Cardiac disease
• Hepatic impairment
• Renal impairment
• Pregnancy
• Breast feeding
JMJ 28
Contraindication
• Cardiac arrhythmias
• Pregnancy
JMJ 29
Drug interactions
• Serotonin syndrome with MAO inhibitors
• Increased risk of bleeding with warfarin &
NSAIDs
JMJ 30
Mirtazapine
JMJ 31
Action
• Noradrenergic and specific serotonergic
antidepressant
JMJ 32
Indications
• Depressive disorder
• Generalized anxiety disorder
• Panic disorder
JMJ 33
Dosage and side effects
• 15-45mg
• Side effects similar to SSRI
• Sexual dysfunction is rare
JMJ 34
Reversible MAO
inhibitors
Moclobemide
JMJ 35
Action
• Reversibly blocks MAO-A
• Indicated in depressive disorder
JMJ 36
Precautions
• Reversible MAOI interact less with food
containing thiamine
• But patients should avoid
• Cheese,
• Yeast extract
• Fermented soy bean products
JMJ 37
Contraindications
• Hepatic impairment
• Pregnancy
• Breast feeding
JMJ 38
Thank You!
JMJ 39

Antidepressants